Corrigendum to “Clinical use of mood stabilizers beyond treatment for bipolar disorder: The REAP-MS study” [Asian J. Psychiatry 85 (2023) 103613] (Asian Journal of Psychiatry (2023) 85, (S1876201823001685), (10.1016/j.ajp.2023.103613))
Issued Date
2023-01-01
Resource Type
ISSN
18762018
eISSN
18762026
Scopus ID
2-s2.0-85163718635
Pubmed ID
37308390
Journal Title
Asian Journal of Psychiatry
Rights Holder(s)
SCOPUS
Bibliographic Citation
Asian Journal of Psychiatry (2023)
Suggested Citation
Chen C.K., Yang S.Y., Park S.C., Jang O.J., Zhu X., Xiang Y.T., Ouyang W.C., Javed A., Sayeed Khan M.N., Grover S., Avasthi A., Kallivayalil R.A., Chee K.Y., Chemi N., Kato T.A., Hayakawa K., Pariwatcharakul P., Maramis M., Seneviratne L., Sim K., Lin S.K. Corrigendum to “Clinical use of mood stabilizers beyond treatment for bipolar disorder: The REAP-MS study” [Asian J. Psychiatry 85 (2023) 103613] (Asian Journal of Psychiatry (2023) 85, (S1876201823001685), (10.1016/j.ajp.2023.103613)). Asian Journal of Psychiatry (2023). doi:10.1016/j.ajp.2023.103650 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/87918
Title
Corrigendum to “Clinical use of mood stabilizers beyond treatment for bipolar disorder: The REAP-MS study” [Asian J. Psychiatry 85 (2023) 103613] (Asian Journal of Psychiatry (2023) 85, (S1876201823001685), (10.1016/j.ajp.2023.103613))
Author's Affiliation
Chang Gung University School of Medicine
Faculty of Health Sciences
Siriraj Hospital
Graduate School of Medical Sciences
The Affiliated Guangji Hospital of Soochow University
University of Sri Jayewardenepura
Hanyang University Guri Hospital
University of Yangon
Services Institute of Medical Sciences Lahore
Universitas Airlangga
Chang Gung Memorial Hospital
Hanyang University College of Medicine
Taipei City Hospital Taiwan
Kuala Lumpur Hospital
Seinan Gakuin University
National University of Singapore
Kaohsiung Medical University
Singapore Institute of Mental Health
Chinese University of Hong Kong
Postgraduate Institute of Medical Education & Research, Chandigarh
Health Management International
Pushpagiri Institute of Medical Sciences
Association for the Improvement of Mental Health Programs
Pakistan Psychiatric Research Centre
Bugok National Hospital
Jianan Psychiatric Center
Regency Specialist Hospital
Hospital Kajang
Shu-Zen Junior College of Medicine and Management
Faculty of Health Sciences
Siriraj Hospital
Graduate School of Medical Sciences
The Affiliated Guangji Hospital of Soochow University
University of Sri Jayewardenepura
Hanyang University Guri Hospital
University of Yangon
Services Institute of Medical Sciences Lahore
Universitas Airlangga
Chang Gung Memorial Hospital
Hanyang University College of Medicine
Taipei City Hospital Taiwan
Kuala Lumpur Hospital
Seinan Gakuin University
National University of Singapore
Kaohsiung Medical University
Singapore Institute of Mental Health
Chinese University of Hong Kong
Postgraduate Institute of Medical Education & Research, Chandigarh
Health Management International
Pushpagiri Institute of Medical Sciences
Association for the Improvement of Mental Health Programs
Pakistan Psychiatric Research Centre
Bugok National Hospital
Jianan Psychiatric Center
Regency Specialist Hospital
Hospital Kajang
Shu-Zen Junior College of Medicine and Management
Other Contributor(s)
Abstract
The authors regret. First, To change the affiliation of Jin Jange. eDepartment of Psychiatry, Bugok National Hospital, Changyeong, the Republic of Korea. to eDepartment of Psychiatry, Haeundae Paik Hospital, Inje University College of Medicine, Busan, South Korea. Second, There is a typo error in the conclusion paragraph of Abstract, Clinicians typically prescribe mood stabilizers as empirically supported treatment to manage mood symptoms in patients with diagnoses other than bipolar disorders, though there is on official indication for these disorders. The costs and benefits of this add-on symptomatic treatment warrant further investigation. Please revise it as Clinicians typically prescribe mood stabilizers as empirically supported treatment to manage mood symptoms in patients with diagnoses other than bipolar disorders, though there is no official indication for these disorders. The costs and benefits of this add-on symptomatic treatment warrant further investigation. The authors would like to apologise for any inconvenience caused. Thank you for your kind help. Best wishes